LABORATORY NEWS
-
Quest Diagnostics Unveils Advanced Transplant Diagnostic Services Featuring Anywhere-Access In The United States
Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today unveiled a comprehensive suite of advanced diagnostics and support services designed to broaden access to laboratory tests for transplanting solid organ, human cells and tissue.
- CND Life Sciences Enters Into Licensing And Collaboration Agreement To Advance Diagnostic Technology For Neurodegenerative Diseases
- Trinity Biotech Welcomes TrinScreen HIV’s Inclusion In The New Kenyan HIV Testing Algorithm
- First-Of-Its-Kind Post-COVID-19 Panels Available At questhealth.com
- Cue Health Receives FDA Emergency Use Authorization For Molecular Mpox Test
ARCHIVED NEWSLETTER
- 03.28.23 -- Trends In FDA FY2022 Inspection-based Warning Letters
- 03.14.23 -- Considerations For Microbial Enumeration Methods When Working With CDMOs
- 02.28.23 -- FDA Adopts ICH Final Guidance On Bioanalytical Method Validation
- 02.14.23 -- Considerations For Sterility Test Methods When Working With CDMOs
- 01.24.23 -- FDA Seeks Comment On Circumstances For Delaying, Denying, Limiting, Or Refusing An Inspection
This website uses cookies to ensure you get the best experience on our website. Learn more